BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1376067)

  • 1. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
    Paglieroni T; MacKenzie MR; Caggiano V
    Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
    [No Abstract]   [Full Text] [Related]  

  • 2. B-1 (CD 5+) B-cells as a marker of immune dysregulation in multiple myeloma.
    MacKenzie MR; Paglieroni TG
    Curr Top Microbiol Immunol; 1995; 194():51-6. PubMed ID: 7534673
    [No Abstract]   [Full Text] [Related]  

  • 3. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
    Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
    J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in immune regulation precede the development of multiple myeloma.
    Paglieroni T; Caggiano V; MacKenzie M
    Am J Hematol; 1992 May; 40(1):51-5. PubMed ID: 1373558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 B lymphocyte antigen in monoclonal gammopathy.
    Bataille R; Duperray C; Zhang XG; Brochier J; Klein B
    Am J Hematol; 1992 Oct; 41(2):102-6. PubMed ID: 1384312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
    Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
    Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell number and function in Graves' disease.
    Wilson R; Pearson C; McKillop JH; Thomson JA
    Autoimmunity; 1994; 17(3):251. PubMed ID: 7524703
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic and functional abnormalities of B cells in myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 1993 Jun; 681():256-63. PubMed ID: 7689307
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
    Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
    J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma.
    Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N
    Anticancer Res; 1994; 14(2B):725-30. PubMed ID: 7516640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expression of CD5 by human B cells and correlation with functional activity.
    Vernino LA; Pisetsky DS; Lipsky PE
    Cell Immunol; 1992 Jan; 139(1):185-97. PubMed ID: 1370255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
    Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
    Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice.
    Kanno K; Okada T; Abe M; Hirose S; Shirai T
    Ann N Y Acad Sci; 1992 May; 651():576-8. PubMed ID: 1376080
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line.
    Scibienski RJ; Paglieroni TG; MacKenzie MR
    Leukemia; 1990 Nov; 4(11):775-80. PubMed ID: 1700238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance.
    Goto H; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Inaba T; Murakami S; Fujita N; Nakagawa M
    Acta Haematol; 1992; 88(2-3):129-35. PubMed ID: 1281599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparative isolation of murine CD5 B cells by panning and magnetic beads.
    Metzger DW; Metzger CA; Ling LA; Hurst JS; Van Cleave VH
    Ann N Y Acad Sci; 1992 May; 651():75-7. PubMed ID: 1376090
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.
    Milani P; Palladini G; Merlini G
    Scand J Clin Lab Invest Suppl; 2016; 245():S113-8. PubMed ID: 27467897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.